Biocon has incorporated a wholly owned subsidiary company namely ‘Biofusion Therapeutics’ on March 18, 2021. The business of wholly owned subsidiary company would be in the field of Research and Development and allied services.
Biocon is India’s largest and Asia’s leading Biotechnology Company with a strategic focus on biopharmaceuticals and research services. It is a fully integrated, innovation driven biopharma enterprise offering affordable solutions for chronic diseases to patient's worldwide.